News
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results